September 27, 2020

Pharmaceutical business at forefront of battle towards COVID-19: Solar Pharma chairman

New Delhi: The pharma business is on the forefront of the battle towards COVID-19 and has responded to this international problem by guaranteeing the provision of medicines regardless of provide chain disruptions, Solar Pharmaceutical Industries Chairman Israel Makov mentioned on Thursday. Scientific trials are being performed to check the effectiveness of many present medicines in treating signs of COVID-19, he added whereas addressing the annual common assembly (AGM) of the corporate.

A number of the international pharmaceutical firms, in addition to few Indian corporations, have additionally initiated scientific trials for the event of a COVID-19 vaccine, Makov mentioned.

“Solar Pharma has ensured ample provides of medicines to its clients the world over regardless of the provision chain disruptions and the lockdown restrictions in varied international locations,” he added.

Modifications at manufacturing services have been made to make sure productiveness, in addition to adherence to all security and hygiene protocols.

The corporate can be leveraging IT expertise instruments to make sure enterprise continuity and to facilitate work-from-home for a lot of workers, Makov mentioned.

“We’re evaluating the potential of some present merchandise which will be helpful in COVID19 therapy. These embrace Nafamostat Mesilate and the phyto-pharmaceutical, AQCH. Each these merchandise are presently present process Section-2 trials in India,” he added.

As a part of the corporate’s company social duty, “we donated sure medicines helpful in managing COVID-19 signs and hand sanitizers price about Rs 250 million to assist the Indian authorities’s COVID-19 pandemic response,” Makov mentioned.

Solar Pharma has additionally organized private protecting tools kits, disinfectants and gloves to assist battle the pandemic, he added.